BBLGW
Bone Biologics Corp (BBLG, BBLGW
NASDAQ · Healthcare · Medical - Devices · US
$7.70
+0.00%Next report
Analyst consensus
- Next report date
- Dec 2, 2026
- EPS estimate
- -$0.19
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.43
- EPS estimate
- -$0.43
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 4
- Avg surprise (4Q)
- -0.1%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$0.43 | -$0.43 | In line | — |
| May 14, 2026 | -$0.43 | -$0.43 | In line | — |
| Feb 25, 2026 | -$0.34 | -$0.34 | In line | — |
| Nov 14, 2025 | -$0.37 | -$0.37 | Miss -0.38% | — |
| Aug 14, 2025 | -$0.58 | -$1.33 | Miss -128.90% | — |
| Dec 30, 2023 | — | -$2.90 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 1, 2027